tirzepatide 2.5mg Zepbound Injection 2.5 mg/0.5 mL — Mountainside Medical How many units is 2.5

Notably, Zepbound is the first GLP-1 drug to be approved for obesity

What to expect in the first 12 weeks Weeks 14: smaller appetite, earlier fullness, sometimes nausea , bloating , or constipation

Not everyone may be eligible for Ozempic ( semaglutide) , which is why consulting a qualified healthcare provider is essential

The findings: no elevated risk of major birth defects compared to unexposed pregnancies

Both medications come with a Boxed Warning about the potential risk of thyroid C-cell tumors

It helps suppress appetite : When tirzepatide targets GLP-1 receptors, the medication reduces cravings and helps you feel full for longer